| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/26/2006 | CN1809347A Selective spirocyclic glucocorticoid receptor modulators |
| 07/26/2006 | CN1807429A Use of fern in extracting harringtonine or homoharringtonine |
| 07/26/2006 | CN1266142C Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/25/2006 | US7081456 N-substitued-4-(3-oxo(thio)chromeno[4,3-c]pyrazol-2(3H)-yl) benzamides or N-substituted-4-(3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl) benzamides; CD80 antigen antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 07/25/2006 | US7081455 sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 07/25/2006 | US7081453 Compounds for treating impaired fundic relaxation |
| 07/20/2006 | WO2006076131A2 Chemical compounds |
| 07/20/2006 | WO2006075925A2 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/20/2006 | WO2006075395A1 β-LACTAM ANTIBIOTIC ACTIVITY ENHANCER AND PROCESS FOR PRODUCING THE SAME |
| 07/20/2006 | WO2006018703A3 Processes for preparation of narwedine and its use in the synthesis of galantamine |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160878 For therapy of central nervous system disorders related to or affected by the 5-HT6 receptor |
| 07/20/2006 | US20060160876 Indole derivatives |
| 07/20/2006 | US20060160874 anticarcinogenic agent; antitumor; antiproliferative; 1-ethyl 5-methyl 3-[(3,5-difluorobenzoyl)amino]-1H-thieno[3,2-c]pyrazole-1,5-dicarboxylate; N-benzyl-3-{[4-(4-ethylpiperazin-1-yl)benzoyl]amino}-1H-thieno[3,2-c]pyrazole-5-carboxamide; can treat neurodegenerative disorders, angiogenesis and metastasis |
| 07/20/2006 | US20060160847 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160830 3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160787 for example 1-(methylthio)-3-methoxy-4-(2-fluorophenyl)azetidin-2-one; induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation |
| 07/20/2006 | CA2594869A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/19/2006 | EP1681291A1 Process for the preparation of norgalanthamine, its isomers, salts and hydrates |
| 07/19/2006 | EP1680428A2 Substituted indole derivatives |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1680415A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | CN1803800A Method for preparing 5-bromine-6-fluoro-8-methyl-1-ethyl-1,3,4,9- tetrahydropyrane[3,4-e] indole-1-ethyl acetate |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078533 Method for the racemization of etodolic acid |
| 07/18/2006 | US7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2256380C Optical resolution of narwedine-type compounds |
| 07/13/2006 | WO2006074003A2 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS |
| 07/13/2006 | WO2006072818A2 Process for preparation of galanthamine |
| 07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
| 07/13/2006 | WO2005123087A3 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 07/13/2006 | WO2004096139A3 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 07/13/2006 | US20060154949 Arylindenopyridines and related therapeutic and prophylactic methods |
| 07/13/2006 | US20060154947 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 07/13/2006 | US20060154945 e.g. (R)-3'-(5-phenyl-thiophen-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5'-oxazolidin]-2'-one; nicotinic acetylcholine receptor agonist; antidepressant, neurodegenerative diseses; Alzheimer's disease, cognitive or attention disorders, smoking cessation, schizophrenia, analgesia |
| 07/13/2006 | US20060154937 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 07/13/2006 | US20060154251 Carboxamide-substituted dyes for analytical applications |
| 07/13/2006 | CA2592904A1 Chiral fused [1,2]imidazo[4,5-c] ring compounds |
| 07/12/2006 | EP1678183A1 Spirofuropyridine aryl derivatives |
| 07/12/2006 | EP1678166A2 Protein kinase inhibitors |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1394156B1 Chromene compound |
| 07/12/2006 | CN1802380A Use of vinca alkaloid and its salt |
| 07/12/2006 | CN1800164A Kukoline C ring modified derivative and its synthesis method |
| 07/12/2006 | CN1264153C 光记录介质 The optical recording medium |
| 07/12/2006 | CN1263751C Novel compounds |
| 07/11/2006 | US7074826 R-NSAID esters and their use |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | CA2325779C New derivatives of 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbzole and 12,13 (pyranosyl)-furo[3,4-c]indol[2,3-a]carbazole, their preparation process and the pharmaceutical compositions therein |
| 07/11/2006 | CA2280100C Alkynyl-substituted camptothecins and process for their preparation |
| 07/11/2006 | CA2227984C Aza-anthracyclinone derivatives |
| 07/11/2006 | CA2213253C Synthesis of (+)-pancratistatin |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 07/06/2006 | WO2006069512A1 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them |
| 07/06/2006 | WO2006051374A3 Arylpiperazines useful as adrenergic receptor antagonists |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060149011 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization therewith |
| 07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/06/2006 | US20060148724 Genipin derivatives and uses thereof |
| 07/06/2006 | US20060148649 Substituted n-aryl nitrogen heterocycles |
| 07/06/2006 | US20060147751 Novel red color emitting compounds and organic electroluminescent device using them |
| 07/06/2006 | DE69635524T2 Antiparasitäre marcfortine und paraherquamide Antiparasitic marcfortines and paraherquamides |
| 07/05/2006 | EP1675847A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1313739B1 Alkylated imidazopyridine derivatives |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | CN1796387A Benzo[b]pyrano[3,2-h]acridin-7-one cinnamate compounds, method of preparation and pharmaceutical composition thereof |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071205 Urogenital disorders; hormone replacement therapy; anticancer agents; contraceptives |
| 07/04/2006 | US7071204 Antitumor agents; topoisomerase inhibitor; leukemia therapy |
| 07/04/2006 | US7071203 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071186 Drug abuse; antiserotonine agents; central nervous system disorders; sleep disorders |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
| 06/29/2006 | WO2006069080A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 06/29/2006 | WO2006068591A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | US20060142506 Heterobifunctional poly(ethylene glycol) and uses thereof |